Aukje K. Mantel‐Teeuwisse

Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union

Thijs J. Giezen, Aukje K. Mantel‐Teeuwisse, Sabine M. J. M. Straus et al. · JAMA · 2008 · 268 citations

Pharmacy, Pharmaceutical Policy, Immunization +16

Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries

Alexandra Cameron, Ilse Roubos, Margaret Ewen et al. · Bulletin of the World Health Organization · 2011 · 189 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Utilization Review +16

Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?

Alexandra Cameron, Aukje K. Mantel‐Teeuwisse, Hubert G.M. Leufkens et al. · Value in Health · 2012 · 175 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +12

Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase

Marjolein J. C. Willemen, Aukje K. Mantel‐Teeuwisse, Sabine M. J. M. Straus et al. · Diabetes Care · 2011 · 146 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +13

Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico

Yared Santa‐Ana‐Téllez, Aukje K. Mantel‐Teeuwisse, Anahí Dreser et al. · PLoS ONE · 2013 · 136 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacy Practice +15